Cargando…

Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease

BACKGROUND: The changes in inspiratory capacity (IC) over time in chronic obstructive pulmonary disease (COPD) patients are unknown. The Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT®) trial included IC measurements. METHODS: IC analysis from UPLIFT® (N = 5992) was pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celli, Bartolome R, Decramer, Marc, Lystig, Theodore, Kesten, Steven, Tashkin, Donald P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443002/ https://www.ncbi.nlm.nih.gov/pubmed/22866681 http://dx.doi.org/10.1186/1465-9921-13-66

Ejemplares similares

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Tiotropium HandiHaler(®) in the treatment of COPD: A safety review
por: Kesten, Steven, et al.
Publicado: (2009)

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials
por: Cooper, Christopher B, et al.
Publicado: (2011)

Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial
por: Celli, Bartolomé R., et al.
Publicado: (2016)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Chronic obstructive pulmonary disease
por: Decramer, Marc, et al.
Publicado: (2012)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease
por: Tashkin, Donald P
Publicado: (2020)

The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease
por: French, Aimee, et al.
Publicado: (2015)

Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Mahler, Donald A.
Publicado: (2019)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Inspiratory muscle training protocol for patients with chronic obstructive pulmonary disease (IMTCO study): a multicentre randomised controlled trial
por: Charususin, Noppawan, et al.
Publicado: (2013)

Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
por: Ohar, Jill A, et al.
Publicado: (2022)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2013)

New Perspectives on Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome R, et al.
Publicado: (2022)

Defining Disease Modification in Chronic Obstructive Pulmonary Disease
por: Halpin, David M.G., et al.
Publicado: (2009)

Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Age of Initiating Smoking: An Independent Predictor of Chronic Obstructive Pulmonary Disease in Later Life
por: Tashkin, Donald P.
Publicado: (2023)

Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
por: Tashkin, Donald P, et al.
Publicado: (2018)

Vitamin D and Chronic Obstructive Pulmonary Disease
por: Janssens, Wim, et al.
Publicado: (2012)

Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease
por: Fuster, Antonia, et al.
Publicado: (2008)

Marijuana Use as a Risk Factor for Chronic Obstructive Pulmonary Disease: Not There Yet
por: Tashkin, Donald P., et al.
Publicado: (2023)

Nutritional Status is Related to Fat-Free Mass, Exercise Capacity and Inspiratory Strength in Severe Chronic Obstructive Pulmonary Disease Patients
por: Sabino, Pollyane Galinari, et al.
Publicado: (2010)

Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap
por: Ishiura, Yoshihisa, et al.
Publicado: (2020)

Total inspiratory and expiratory impedance in patients with severe chronic obstructive pulmonary disease
por: Silva, Karla Kristine Dames, et al.
Publicado: (2011)

Inspiratory and expiratory CT analyses of the diaphragmatic crus in chronic obstructive pulmonary disease
por: Wada, Shinji, et al.
Publicado: (2022)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD)
por: Ammous, Omar, et al.
Publicado: (2023)

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents
por: Tashkin, Donald P, et al.
Publicado: (2010)

Proprioceptive Changes Impair Balance Control in Individuals with Chronic Obstructive Pulmonary Disease
por: Janssens, Lotte, et al.
Publicado: (2013)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2015)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Dynamic change in respiratory resistance during inspiratory and expiratory phases of tidal breathing in patients with chronic obstructive pulmonary disease
por: Yamauchi, Yasuhiro, et al.
Publicado: (2012)

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
por: Tashkin, Donald P, et al.
Publicado: (2020)

Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Wu, Ann Chen, et al.
Publicado: (2019)

Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease
por: Chen, Shih-Yu, et al.
Publicado: (2020)

Maximal Voluntary Breath-Holding Tele-Inspiratory Test in Patients with Chronic Obstructive Pulmonary Disease
por: Hedhli, Abir, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bsd9api67fu5mkghfla897ck2r